Medizinische Fakultät


close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
Data entrepreneurs - a course for professionals (DECP) (PM-EUC-EIT-09_DECP 2024) Jan. 1, 2024 - Dec. 31, 2024 Identifizierung von molekularen Ursachen hypoxiebedingter orofazialer Spalten Dec. 1, 2023 - Nov. 30, 2024 Deciphering LIN28B as a biomarker in squamous cell lung carcinomas for treatment with PD-1/PD-L1 signaling blockade and evaluating combined anti-VEGFR2 with PD-1/PD-L1 signaling lockade as a novel therapy option Dec. 1, 2021 - Nov. 30, 2024 J094: Decoding the effect of inflammatory bowel disease on microglia activation and synucleinopathy Dec. 1, 2021 - Nov. 30, 2024 Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. (HYPERBOOST) HYPERBOOST: Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. Dec. 1, 2020 - Nov. 30, 2024 Development and investigation of isotope-labelled antagonists for the orexin 1 receptor (OX1R) with subtype selectivity over OX2R July 1, 2020 - Nov. 30, 2024 P142: Investigation of stromal IL36R signaling during intestinal inflammation and fibrosis Nov. 16, 2023 - Nov. 15, 2024 IZKF-N8 Lysosomes & glial cells: Lysosomal dysfunction within glial cells Feb. 16, 2021 - Nov. 15, 2024 P122: Breast tumor engineering in the arteriovenous loop model May 1, 2023 - Oct. 31, 2024 MikroHyperTumlmmun - Entwicklung praxisrelevanter Hyperthermiesysteme zur Verbesserung multimodaler klinischer Konzepte für die Induktion von Antitumor-Immunantworten (ST-BFS_MikroHyperTumImmun) Nov. 1, 2021 - Oct. 31, 2024